You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
潤達醫療(603108.SH)子公司擬1.505億元收購蘇州潤贏35%股權
格隆匯 06-30 19:22

格隆匯 6 月 30日丨潤達醫療(603108.SH)公佈,公司的全資子公司杭州潤達醫療管理有限公司(“杭州潤達”或“受讓方”)擬收購寧波梅山保税港區國金鼎興三期股權投資基金中心(有限合夥)(“鼎興三期”)、寧波梅山保税港區鼎興鼎泰股權投資合夥企業(有限合夥)(“鼎興鼎泰”)、上海潤達盛瑚投資管理中心(有限合夥)(“潤達盛瑚”)三方合計持有的蘇州潤贏醫療設備有限公司(“蘇州潤贏”或“標的公司”)35%股權,交易金額為1.505億元。

公司近年來在江蘇地區原有業務規模近1億,以微生物及第三方質控專業服務業務為主,蘇州潤贏是江蘇地區醫學實驗室綜合服務提供商,與公司的業務協同性較強,且業務規模近5億,在該地區業務領先的服務商。此次股權轉讓完成後,杭州潤達持有蘇州潤贏35%的股權。此次投資蘇州潤贏,旨在進一步增強長三角地區體外診斷服務專業化領域的市場競爭力,豐富綜合服務內容、加強綜合服務能力,夯實公司華東地區的市場領先地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account